The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.
Saved in:
| Title: | The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review. |
|---|---|
| Authors: | Chen Y; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Zhao J; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Wang Y; School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Ge L; Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China., Kwong JS; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan., Lan J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Zhang R; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Zhao H; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Hu L; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Wang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Sun S; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Tan S; Office of Health Insurance Administration, Guizhou Provincial People's Hospital, Guiyang, China., Lin X; School of Public Health, The key Laboratory of Environmental Pollution Monitoringand Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China., He R; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Zheng W; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Li X; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China., Zhang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Jan 15; Vol. 15, pp. 1530999. Date of Electronic Publication: 2025 Jan 15 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2024.1530999 |
